ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia

Leukemia

Volumn 11, Issue 9, 1997, Pages 1459-1464

  Cave H ^a   Cacheux, V ^a   Raynaud, S ^b   Brunie, G ^a   Bakkus, M ^c   Cochaux, P ^d   Preudhomme, C ^e   Lai J L ^f   Vilmer, E ^a   Grandchamp, B ^a,g  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CNRS   (France)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e Institut de Recherche sur le Cancer de Lille   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g INSERM   (France)

Author keywords

Acute lymphoblastic leukemia; Deletion; ETV6; ETV6 AML1; Loss of heterozygosity; t(12; 21)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MICROSATELLITE DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 12P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 16944367034     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400798     Document Type: Article

References (13)

1. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion map of hematological neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosom Cancer 1993; 8: 205-218.
2. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 38-44.
3. Cavé H, Gérard B, Martin E, Guidal C, Devaux I, Weissenbach J, Elion J, Vilmer E, Grandchamp B. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1. Blood 1995; 86: 3869-3875.
4. Takeuchi S, Bartram CR, Miller CW, Reiter A, Seriu T, Zimmerann M, Schrappe M, Mori N, Slater J, Miyolshi I, Koeffler HP. Acute lymphoblastic leukemia of childhood. Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996; 87: 3368-3374.
5. Lasko D, Cavenee W, Nordenskjöld M. Loss of constitutional heterozygosity in human cancer. Ann Rev Biochem 1991; 25: 281-314.
6. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891-2899.
7. Wlodarska I, Marynen P, La Starza R, Mecucci C, Van Den Berghe H. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberrations in different hematological malignancies. Cytogenet Cell Genet 1996; 72: 229-235.
8. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, Bohlander SK. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525-1533.
9. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 1996; 87: 324-330.
10. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307-316.
11. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel GA, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 1995; 10: 1511-1519.
12. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM. The novel activation of ABL by fusion to an ETS-related gene, TEL. Cancer Res 1995; 55: 34-38.
13. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 1995; 85: 2848-2852.